Despite advancements, achieving perfect selectivity remains a challenge due to:
Heterogeneity of Cancer: Cancer cells within the same tumor can vary greatly, making it difficult to target all cells effectively. Similarities Between Cancer and Normal Cells: Some cancer cells share characteristics with normal cells, making it hard to target cancer cells without affecting healthy ones. Drug Resistance: Cancer cells can develop resistance to therapies, necessitating combination treatments or new drugs.
